Leading the Way in Life Science Technologies

GEN Exclusives

More »

Sounds of Science Podcasts

More »
June 28, 2017

SARS and MERS Inhibited by Ebola Drug

Sounds of Science Podcast

SARS and MERS Inhibited by Ebola Drug

Source: NIAID

  • A research team from Vanderbilt University, University of North Carolina, and Gilead Sciences has just released new findings in Science Translational Medicine describing how a new antiviral drug candidate inhibits a broad range of coronaviruses, including SARS and MERS. Listen now for more details!


Related content

  • Finally! A cure for the Biotech News Blues.

  • Join 110,000 colleagues who rely on GEN Highlights for breaking news and exclusive articles shaping today’s life science tools and technologies.

  • Oops! Please type your email in the following format: [email protected] An error has occurred. Please contact Customer Service at [email protected]
  • You’re all set! Thank you for subscribing to GEN Highlights.